Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
129,205,921
-
Share change
-
-15,103,211
-
Total reported value
-
$2,550,743,065
-
Put/Call ratio
-
102%
-
Price per share
-
$19.73
-
Number of holders
-
315
-
Value change
-
-$263,240,299
-
Number of buys
-
116
-
Number of sells
-
127
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2019
As of 31 Dec 2019,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
315 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,205,921 shares.
The largest 10 holders included
GLENVIEW CAPITAL MANAGEMENT, LLC, PAULSON & CO. INC., Adelphi Capital LLP, VANGUARD GROUP INC, MACQUARIE GROUP LTD, PRICE T ROWE ASSOCIATES INC /MD/, BANK OF AMERICA CORP /DE/, NORTHERN TRUST CORP, Mondrian Investment Partners LTD, and Parametric Portfolio Associates LLC.
This page lists
320
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.